September 2006 On the Cover Cross-functional teams: Models of success Representation from all the key disciplines — toxicology, pharmacovigilance, clinical research, pharmacology, manufacturing, legal, and, yes, marketing — is essential for drug-development success today. Features Name that brand Choosing a brand name is the most defining moment in a pharmaceutical product’s life. 28 IRBs: The safety gatekeepers Current pressures to speed drugs to market have resulted in the increased use of independent, centralized institutional review boards. Managing lifestyles with medicine Consumers who have the desire to improve their quality of life are looking for curative powers from select pharmaceuticals. Pharma has the data but not the information Michael Rosenberg, M.D., MPH, of Health Decisions Inc., discusses why, compared with other large industries, pharma’s automation processes lag behind. Graham Allaway, Ph.D. — The discovery bug Whether exploring the open seas in his single-handed Laser or investigating uncharted areas in virology, Dr. Allaway attends to both with equal passion, commitment, and focus. DIA 2006 — Annual Conference The 42nd Annual Meeting of the Drug Information Association, held in June 2006, drew record attendance to Philadelphia. In Every Issue Letter from the Editor UpFront A brief review of industry news at press time GlobalPerspective Bill McHale provides creative solutions for staffing global trials. PharmaOutlet Anthony Mason discusses the new wave of social networking. PharmaTrax Sales, marketing, and R&D trends from industry analysts What’s New New healthcare-related products, services, and companies E-Media New electronic and Web-based applications, sites, and technologies On The Calendar Industry events Talent Pool Executive appointments and promotions

Download PDF